A once-scrapped Alzheimer’s drug may work after all, new analyses suggest

At the highest doses, aducanumab slowed mental decline, the drug developer claims


By targeting sticky globs of amyloid (red) in the brains of people with Alzheimer’s, a new drug may offer a way to slow the disease’s spread.

Martin M. Rotker/Science Source

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content